Millennium wins injunction against Juno over generic cancer drug
Biopharmalex 2018-08-27 11:27 am By Christine Caulfield | Melbourne
Please login to bookmark Close

US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au